Fermenta Biotech Ltd - 506414 - Successful Closure Of US FDA Inspection At Company''s Facility
US FDA has issued an Establishment Inspection Report with no observations for Company''s facility at Dahej, Gujarat, India.06-07-2024
06-07-2024
Fermenta Biotech Ltd - 506414 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 201501-07-2024
Fermenta Biotech Ltd - 506414 - Closure of Trading Window
Closure of trading window from July 1, 2024.28-06-2024
Fermenta Biotech Ltd - 506414 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot
Post Ballot result, regulation 44, scrutinizer report20-06-2024
Fermenta Biotech Ltd - 506414 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Post Ballot results, regulation 44 results, scrutinizers report20-06-2024
Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Investor Presentation
Corrigendum - Intimation of Earnings Presentation for Quarter 4 of Financial year 2023-24 and FY 2023-24.12-06-2024
Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Investor Presentation
Intimation of Earnings presentation for Quarter 4 FY 2023-24 and FY 2023-2411-06-2024
Fermenta Biotech Ltd - 506414 - Update On The Intimation Pursuant To Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation 2015
Update on the Development Agreement for development of the Company''s Land at Thane10-06-2024
Fermenta Biotech Ltd - 506414 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 201531-05-2024
Fermenta Biotech Ltd - 506414 - Clarification On Record Date
Clarification on record date for the purpose of 72nd Annual General Meeting and payment of Dividend30-05-2024